MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Venture Capital: Risk Capital_Angel, Venture, Sovereign Wealth Investor Companies & Organizations
Keiretsu Forum
Industry: Silicon Valley, California
AltruBio, Inc
Attachments
AltruBio
Parents
*Architects: BioPharmaceuticals_Inflammation, Allergy & Autoimmune
Industry: Silicon Valley, California
Children
AltruBio has the first-in-class checkpoint regulator PGSL-1 agonist antibodies which can be leveraged as the technology platform to address the needs in many immunological and inflammatory diseases.
AltruBio is a clinical stage biopharmaceutical company with the strength in developing novel biologics for the treatment of immunological diseases with high unmet medical needs.
AltruBio's pipeline is focused on the depletion of unwanted activated T-cells with proof of mechanism in four autoimmune and inflammatory diseases.
Founded 2000
Judy Chou, PHD CEO AND PRESIDENT, ALTRUBIO, INC. (2021)
Redwood City, California